An Nrf2 inhibitor (ML385) used to further confirm the protective effect of Bcl3 deficiency was based on activation of the Nrf2 pathway (Figure 8A).35 The gene discussed is NFE2L2; the disease is hyperinsulinemic hypoglycemia, familial, 4.